Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfram Osen

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Detection of spontaneous CD4+ T-cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic miceAnnette Paschen, Mingxia Song, Wolfram Osen, et al.
Journal of Innate Immunity|June 12, 2022
Adoptively Transferred in vitro-Generated Myeloid-Derived Suppressor Cells Improve T-Cell Function and Antigen-Specific Immunity after Traumatic Lung InjuryMonika Kustermann, Prasad Dasari, Ingrid Knape, et al.
BMC Cancer|September 15, 2019
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic miceKrishna Das, David Eisel, Mathias Vormehr, et al.
Journal of Virology|March 29, 2003
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 micePeter Ohlschläger, Wolfram Osen, Kerstin Dell, et al.
Cancer Letters|October 2, 2022
Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor modelLaura Hartmann, Wolfram Osen, Oliver L Eichmüller, et al.
International Journal of Cancer|November 13, 2014
Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic miceAdriane Gardyan, Wolfram Osen, Inka Zörnig, et al.
Viruses|February 27, 2020
Measles Vaccines Designed for Enhanced CD8<sup>+</sup> T Cell ActivationElena Busch, Kristina D Kubon, Johanna K M Mayer, et al.
Cell Stem Cell|May 6, 2022
Antigen presentation safeguards the integrity of the hematopoietic stem cell poolPablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Detection of spontaneous CD4+ T-cell responses in melanoma patients against a tyrosinase-related protein-2-derived epitope identified in HLA-DRB1*0301 transgenic miceAnnette Paschen, Mingxia Song, Wolfram Osen, et al.
Journal of Innate Immunity|June 12, 2022
Adoptively Transferred in vitro-Generated Myeloid-Derived Suppressor Cells Improve T-Cell Function and Antigen-Specific Immunity after Traumatic Lung InjuryMonika Kustermann, Prasad Dasari, Ingrid Knape, et al.
BMC Cancer|September 15, 2019
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic miceKrishna Das, David Eisel, Mathias Vormehr, et al.
Journal of Virology|March 29, 2003
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 micePeter Ohlschläger, Wolfram Osen, Kerstin Dell, et al.
Cancer Letters|October 2, 2022
Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor modelLaura Hartmann, Wolfram Osen, Oliver L Eichmüller, et al.
International Journal of Cancer|November 13, 2014
Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic miceAdriane Gardyan, Wolfram Osen, Inka Zörnig, et al.
Viruses|February 27, 2020
Measles Vaccines Designed for Enhanced CD8<sup>+</sup> T Cell ActivationElena Busch, Kristina D Kubon, Johanna K M Mayer, et al.
Cell Stem Cell|May 6, 2022
Antigen presentation safeguards the integrity of the hematopoietic stem cell poolPablo Hernández-Malmierca, Dominik Vonficht, Alexandra Schnell, et al.
Pageof 4